Cargando…

The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients

OBJECTIVE: The objective of this study was to examine the effects of angiotensin-converting enzyme inhibitors on peritoneal membrane transport, peritoneal protein loss, and proteinuria in peritoneal dialysis patients. METHODS: Fifty-four peritoneal dialysis patients were included in the study. The p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basturk, Taner, Unsal, Abdulkadir, Koc, Yener, Nezaket, Eren, Ahbap, Elbis, Sakaci, Tamer, Sevinc, Mustafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2012
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3416891/ https://www.ncbi.nlm.nih.gov/pubmed/22948453 http://dx.doi.org/10.6061/clinics/2012(08)04

Ejemplares similares

Comparison of lung ultrasound and other volumetric methods in peritoneal dialysis patients
por: Sevinc, Mustafa, et al.
Publicado: (2021)

Clinical outcomes and mortality in elderly peritoneal dialysis patients
por: Sakacı, Tamer, et al.
Publicado: (2015)

Effects of human Umbilical Cord Stem Cells and Granulocyte Colony- Stimulating Factor (G-CSF) on Carbon Tetrachloride-Induced Nephrotoxicity
por: Koc, Yener, et al.
Publicado: (2012)

Unexpectedly High Prevalence of Low Alpha-Galactosidase A Enzyme Activity in Patients with Focal Segmental Glomerulosclerosis
por: Hasbal, Nuri Baris, et al.
Publicado: (2020)

Comparison of Exit-Site Infection Frequency in Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis Patients: A Single-Center Experience
por: Sevinç, Mustafa, et al.
Publicado: (2019)

Factors Associated with Long-Term Survival in Maintenance Hemodialysis Patients: A 5-Year Prospective Follow-Up Study
por: Ahbap, Elbis, et al.
Publicado: (2022)

Pentraxin-2 is Associated with Renal Fibrosis in Patients Undergoing Renal Biopsy
por: Basturk, Taner, et al.
Publicado: (2020)

Can eculizumab be discontinued in aHUS?: Case report and review of the literature
por: Sahutoglu, Tuncay, et al.
Publicado: (2016)

Serum VEGF-C levels as a candidate biomarker of hypervolemia in chronic kidney disease
por: Sahutoglu, Tuncay, et al.
Publicado: (2017)

Aldosterone Resistance Due to Tacrolimus: A Case Report
por: Çağlayan, Feyza Bayraktar, et al.
Publicado: (2018)

Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report
por: Sevinc, Mustafa, et al.
Publicado: (2015)

The relationship between serum albumin levels and 24-h ambulatory blood pressure monitoring recordings in non-diabetic essential hypertensive patients
por: Ahbap, Elbis, et al.
Publicado: (2016)

Does Residual Renal Function Have a Beneficial Effect on Patient and Technique Survival in Peritoneal Dialysis Patients?
por: Ahbap, Elbis, et al.
Publicado: (2018)

Outcome of 121 patients with renal amyloid a amyloidosis
por: Ahbap, Elbis, et al.
Publicado: (2014)

Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic
por: Sevinc, Mustafa, et al.
Publicado: (2021)

Encapsulating peritoneal sclerosis as a late complication of peritoneal dialysis
por: Oran, Ebru, et al.
Publicado: (2015)

Membranoproliferative glomerulonephritis and a rare bleeding disorder: factor X deficiency
por: Basturk, T., et al.
Publicado: (2010)

Renal Damage Frequency in Patients with Solitary Kidney and Factors That Affect Progression
por: Basturk, T., et al.
Publicado: (2015)

Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban
por: Hasbal, Nuri Barış, et al.
Publicado: (2017)

Peritoneal dialysis-related peritonitis: challenges and solutions
por: Salzer, William L
Publicado: (2018)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Effects of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events among peritoneal dialysis patients: A protocol for systematic review
por: Nochaiwong, Surapon, et al.
Publicado: (2020)

The effects of the recommended dose of creatine monohydrate on kidney function
por: Taner, Basturk, et al.
Publicado: (2011)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

Peritoneal Dialysis Complicated by Sclerosing Peritonitis
por: Jiang, Zhifeng, et al.
Publicado: (2022)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

The time for surgery of peritonitis associated with peritoneal dialysis
por: Mihalache, O, et al.
Publicado: (2016)

Peritoneal-pleural leak improved by switching from continuous ambulatory peritoneal dialysis to automated peritoneal dialysis
por: Jung, Jong Hwan
Publicado: (2018)

Continuous Ambulatory Peritoneal Dialysis Peritonitis Guidelines – Consensus Statement of Peritoneal Dialysis Society of India - 2020
por: Jeloka, Tarun K., et al.
Publicado: (2021)

The effects of serum leptin levels on thrombocyte aggregation in peritoneal dialysis patients
por: Bakirdogen, Serkan, et al.
Publicado: (2016)

Calcium balance in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) cyclers
por: Davenport, Andrew
Publicado: (2023)

Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress
por: Roumeliotis, Stefanos, et al.
Publicado: (2020)

Peritoneal dialysis in Peru
por: Vélez-Segovia, E., et al.
Publicado: (2014)

Psychiatrist and Peritoneal Dialysis
por: Klarić, D., et al.
Publicado: (2022)

Peritoneal dialysis: why not?
por: Andreoli, Maria Claudia Cruz, et al.
Publicado: (2023)

Prescribing and peritoneal dialysis
por: Reimann, Frank, et al.
Publicado: (2023)

A Case of Peritoneal Dialysis-related Peritonitis Caused by Aeromonas Hydrophila in the Patient Receiving Automated Peritoneal Dialysis
por: Kim, Hyun Jin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c2qkkr1fm6jtjnvoviae1f25u4